Literature DB >> 8443038

Assessment of the precorneal residence of an ophthalmic ointment in healthy subjects.

J L Greaves1, C G Wilson, A T Birmingham.   

Abstract

1. The precorneal residence of an ophthalmic ointment radiolabelled by inclusion of technetium-99m tin colloid was assessed in seven volunteer subjects using the technique of gamma scintigraphy and compared with a solution of 0.3% w/v hydroxypropylmethylcellulose, (HPMC) radiolabelled by inclusion of technetium-99m diethylenetriaminepentaacetic acid in the same subjects. 2. The mean half-times (+/- s.d.) of corneal residence were 6490 +/- 5404 s (108 min) for the ointment and 13 +/- 24 s for the 0.3% w/v HPMC solution (P < 0.01). 3. The area-under-curve value (AUC(0,540 s)), which reflects the total residence time of the preparation on the ocular surface, was calculated for each vehicle in each subject. The mean (+/- s.d.) AUC(0,540 s) value for the ointment was 42170 (+/- 5032)% s and for the 0.3% w/v HPMC solution it was 8394 (+/- 4641)% s (P < 0.01).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8443038      PMCID: PMC1381513     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  A comparison of the precorneal residence of an artificial tear preparation in patients with keratoconjunctivitis sicca and normal volunteer subjects using gamma scintigraphy.

Authors:  J L Greaves; C G Wilson; N R Galloway; A T Birmingham; O Olejnik
Journal:  Acta Ophthalmol (Copenh)       Date:  1991-08

Review 2.  Pharmacokinetics of topically applied ophthalmic drugs.

Authors:  J W Shell
Journal:  Surv Ophthalmol       Date:  1982 Jan-Feb       Impact factor: 6.048

3.  Ocular bioavailability and systemic loss of topically applied ophthalmic drugs.

Authors:  T F Patton; M Francoeur
Journal:  Am J Ophthalmol       Date:  1978-02       Impact factor: 5.258

4.  Direct physical demonstration of oily layer on tear film surface.

Authors:  G E Brauninger; D O Shah; H E Kaufman
Journal:  Am J Ophthalmol       Date:  1972-01       Impact factor: 5.258

5.  Effects of drug vehicles on ocular uptake of tetracycline.

Authors:  R E Hardberger; C Hanna; R Goodart
Journal:  Am J Ophthalmol       Date:  1975-07       Impact factor: 5.258

6.  Scintigraphic assessment of an ophthalmic gelling vehicle in man and rabbit.

Authors:  J L Greaves; C G Wilson; A Rozier; J Grove; B Plazonnet
Journal:  Curr Eye Res       Date:  1990-05       Impact factor: 2.424

7.  Effects of drug vehicles on ocular contact time.

Authors:  R Hardberger; C Hanna; C M Boyd
Journal:  Arch Ophthalmol       Date:  1975-01

Review 8.  Effect of drug vehicle on human ocular retention of topically applied tetracycline.

Authors:  J Y Massey; C Hanna; R Goodart; T Wallace
Journal:  Am J Ophthalmol       Date:  1976-02       Impact factor: 5.258

9.  Topically applied pilocarpine. Human pupillary response as a function of drop size.

Authors:  R R File; T F Patton
Journal:  Arch Ophthalmol       Date:  1980-01
  9 in total
  8 in total

Review 1.  Nuclear medicine techniques in the evaluation of pharmaceutical formulations.

Authors:  A C Perkins; M Frier
Journal:  Pharm World Sci       Date:  1996-06

2.  Time course of changes in ocular wavefront aberration after administration of eye ointment.

Authors:  T Hiraoka; T Yamamoto; F Okamoto; T Oshika
Journal:  Eye (Lond)       Date:  2012-07-20       Impact factor: 3.775

3.  Sustained ocular delivery of ciprofloxacin using nanospheres and conventional contact lens materials.

Authors:  Rahul Garhwal; Sally F Shady; Edward J Ellis; Jeanne Y Ellis; Charles D Leahy; Stephen P McCarthy; Kathryn S Crawford; Peter Gaines
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-13       Impact factor: 4.799

Review 4.  Engineering nanomedicines for improved melanoma therapy: progress and promises.

Authors:  Di Bei; Jianing Meng; Bi-Botti C Youan
Journal:  Nanomedicine (Lond)       Date:  2010-11       Impact factor: 5.307

Review 5.  Perspectives on Physicochemical and In Vitro Profiling of Ophthalmic Ointments.

Authors:  Quanying Bao; Diane J Burgess
Journal:  Pharm Res       Date:  2018-10-15       Impact factor: 4.200

6.  Effect of Particle Size and Viscosity of Suspensions on Topical Ocular Bioavailability of Budesonide, a Corticosteroid.

Authors:  Sunil Vooturi; David Bourne; Jiban Jyoti Panda; Stephanie Choi; Hyewon Kim; Sarath K Yandrapu; Uday B Kompella
Journal:  J Ocul Pharmacol Ther       Date:  2020-07-14       Impact factor: 2.850

Review 7.  Relevance of Lipid-Based Products in the Management of Dry Eye Disease.

Authors:  Jean-Sébastien Garrigue; Mourad Amrane; Marie-Odile Faure; Juha M Holopainen; Louis Tong
Journal:  J Ocul Pharmacol Ther       Date:  2017-09-28       Impact factor: 2.671

8.  Development of In Vitro Methodologies to Investigate Binding by Sodium Hyaluronate in Eye Drops to Corneal Surfaces.

Authors:  Udo Bock; Von Deylen D; Jochner M; Doerr M; Stäbler C; Reichl S
Journal:  Open Ophthalmol J       Date:  2018-07-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.